Daptomycin as supportive treatment option in patients developing mediastinitis after open cardiac surgery

Area of Science:

• Cardiology
• Infectious Diseases
• Surgical Critical Care

Background:

• Mediastinitis is a serious complication post-cardiac surgery.
• Despite advances, mediastinitis treatment remains challenging.
• This study explores daptomycin as a supportive therapy for post-cardiac surgery mediastinitis.

Purpose of the Study:

• To evaluate the efficacy of daptomycin as supportive therapy for mediastinitis after open cardiac surgery.
• To assess the safety and tolerability of daptomycin in this patient population.

Main Methods:

• Retrospective review of 21 patients diagnosed with mediastinitis post-cardiac surgery.
• All patients underwent surgical debridement and received daptomycin antibiotic therapy.
• Patient outcomes were tracked until discharge or death.

Main Results:

• 90.5% of patients showed clinical improvement with daptomycin and surgical treatment.
• Median time to clinical improvement was 5 days.
• Daptomycin was well-tolerated with no major observed adverse events.

Conclusions:

• Daptomycin is a beneficial supportive treatment option for mediastinitis following cardiac surgery.
• The findings offer valuable insights into managing this severe post-operative complication.
• Further research may confirm daptomycin's role in treating post-sternotomy mediastinitis.